← All stocks

INOVIO PHARMACEUTICALS, INC.

INO Net selling
CIK 0001055726 #4191 in the set updated 18 Sep 2026
Bought (120 mo)
$263.15K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$19.50M
$0.00 on a plan · $6.83M straight out of an exercise
Sold at will
$12.67M
40 of 72 sales
Net
−$19.24M
−$12.41M against sales at will

By person

19 insiders · 80 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kim Jong Joseph
Chief Executive Officer
$69.98K (1)
$12.63M (15)
−$12.56M
2,346,000
$1.31M
−38.5%
KIES PETER
CFO
$3.03M (10) scheduled
−$3.03M
47,354
$26.52K
Shea Jacqueline Elizabeth
Chief Executive Officer
$1.57M (8) scheduled
−$1.57M
111,021
$62.17K
Humeau Laurent
Chief Scientific Officer
$59.99K (2)
$1.03M (5)
−$974.96K
46,823
$26.22K
Weiner David B.
Director
$914.15K (19) scheduled
−$914.15K
87,592
$49.05K
BENITO SIMON X
Director
$291.16K (10) scheduled
−$291.16K
12,191
$6.83K
COLLINS MORTON
Director
$133.19K (1)
+$133.19K
365,230
$204.53K
+14.8%
Zoth Lota S.
Director
$37.78K (5)
−$37.78K
8,726
$4.89K
Sardesai Niranjan
Chief Operating Officer
123,486
$69.15K
+155.0%
DHILLON AVTAR S
Director
106,002
$59.36K
+67.4%
Bagarazzi Mark
Chief Medical Officer
100,672
$56.38K
+391.3%
Cabrera Angel
Director
75,602
$42.34K
+81.1%
Sumner Michael John
Chief Medical Officer
42,038
$23.54K
MAHMOUD ADEL
Director
22,669
$12.69K
+353.4%
YARNO WENDY L
Director
10,512
$5.89K
Miller Ann Calby
Director
9,877
$5.53K
Shepard Jay
Director
9,209
$5.16K
DANSEY ROGER D
Director
8,916
$4.99K
Bickerstaff George
Director
4,090
$2.29K

No percentages here. This company's share count has moved by a factor of 4.0 over the window, from 26,099,991 to 103,397,518 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
DHILLON AVTAR S
6 Dec 2018
Director
Exercised, kept
25,000
$2.00
$50.00K
Kim Jong Joseph
28 Jul 2017
Chief Executive Officer
Exercised, kept
61,325
$5.08
$311.53K
Sardesai Niranjan
4 Jan 2017
Chief Operating Officer
Exercised, kept
3,680
$6.12
$22.52K
Sardesai Niranjan
4 Jan 2017
Chief Operating Officer
Exercised, kept
6,133
$6.12
$37.53K

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 32
Sales at will 40
Transactions with no price 0
Shares from compensation/vesting 6,690,708
Sales filed before the plan box existed 39
History held since 4 Jan 2017